Pyxis Oncology Inc
(PYXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2006 | 12-1994 | 12-1993 | 12-1992 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | 11,896 | 25,517 | 11,897 |
| Depreciation Amortization | N/A | N/A | 726 | 716 | 616 |
| Other Working Capital | N/A | N/A | -7,841 | -37,711 | -7,743 |
| Other Operating Activity | 0 | 0 | 3,184 | 17,764 | 3,293 |
| Operating Cash Flow | $N/A | $N/A | $7,965 | $6,286 | $8,064 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -2,622 | -1,221 | -1,050 |
| Net Acquisitions | N/A | N/A | -2,898 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -19,735 | -12,087 | -30,380 |
| Investing Cash Flow | $N/A | $N/A | $-25,255 | $-13,308 | $-31,430 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 544 | -988 | 60,725 |
| Financing Cash Flow | $N/A | $N/A | $544 | $-988 | $60,725 |
| Beginning Cash Position | N/A | N/A | 30,863 | 38,873 | 1,514 |
| End Cash Position | N/A | N/A | 16,962 | 30,863 | 38,873 |
| Net Cash Flow | $N/A | $N/A | $-13,901 | $-8,010 | $37,359 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | N/A | 7,965 | 6,286 | 8,064 |
| Free Cash Flow | 0 | 0 | 7,965 | 6,286 | 8,064 |